Meitheal Pharmaceuticals Inc. lists 63 NDCs in the CMS NADAC file (62 generic, 1 brand), at an average NADAC of $22.62 per unit, with a week-over-week move of -0.7% across products that moved. The firm's full portfolio, pricing trend are listed below.
Total Drugs
63
62G / 1B
Avg Price / Unit
$22.6209
$0.05 – $602.95
Avg 7d Change
-0.71%
Across 38 drugs with changes
7d Activity
16↑22↓25 flat
of 63 total drugs
Portfolio Price Trend
Monthly average NADAC price across all drugs
Keep following this manufacturer
These next-step links connect the manufacturer page to the markets, classes, and trend views most likely to deepen research.
How many drugs does Meitheal Pharmaceuticals Inc. make?
Meitheal Pharmaceuticals Inc. lists 63 NDCs in the CMS NADAC file — 62 generic and 1 brand product.
What is the average price of Meitheal Pharmaceuticals Inc. drugs?
The average NADAC across Meitheal Pharmaceuticals Inc.'s portfolio is $22.6209 per unit, ranging from $0.0479 to $602.9450.
What types of drugs does Meitheal Pharmaceuticals Inc. make?
Meitheal Pharmaceuticals Inc. makes drugs across 21 FDA pharmacologic classes. The most common by NDC count are Low Molecular Weight Heparin (23), Anti-coagulant (7), Unfractionated Heparin (7), Lipopeptide Antibacterial (5), Vitamin B12 (4).
Has Meitheal Pharmaceuticals Inc. had any drug recalls?
No FDA enforcement recalls are matched to Meitheal Pharmaceuticals Inc. in the openFDA feed.
How has Meitheal Pharmaceuticals Inc.'s pricing changed recently?
Over the past 7 days, 16 Meitheal Pharmaceuticals Inc. products rose and 22 fell, with a portfolio-wide average change of -0.7%.